CFO Taylor Lawrence’s June 10 Sale of 36,000 Shares Mirrors Routine RSU Vesting, Not a Warning Signal for Orchestra BioMed Stock.
Insightful insider sale: CFO Taylor Andrew Lawrence sells 36k Orchestra BioMed shares amid RSU vesting, revealing steady confidence and minimal short‑term impact.
3 minutes to read